Skip to Content

  • Search

View Additional Section Content

EMPEROR -A phase III randomized, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with preserved Ejection Fraction (HFPEF).

Clinical Trial Categories

  • Cardiology
Contact
Annette Fudala, RMA, CRC at 215-355-9770

Location

  • Feasterville Family Health Care Center N/A
    1665 Bustleton Pike
    Feasterville, PA 19053

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM

Clinical Trials Details